• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重角色基因:兼具致癌和抑癌功能的基因。

Double agents: genes with both oncogenic and tumor-suppressor functions.

作者信息

Shen Libing, Shi Qili, Wang Wenyuan

机构信息

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, China.

Department of Rehabilitation Medicine, Hua Shan Hospital, Fudan University, Shanghai, 200040, China.

出版信息

Oncogenesis. 2018 Mar 13;7(3):25. doi: 10.1038/s41389-018-0034-x.

DOI:10.1038/s41389-018-0034-x
PMID:29540752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5852963/
Abstract

The role of genetic components in cancer development is an area of interest for cancer biologists in general. Intriguingly, some genes have both oncogenic and tumor-suppressor functions. In this study, we systematically identified these genes through database search and text mining. We find that most of them are transcription factors or kinases and exhibit dual biological functions, e.g., that they both positively and negatively regulate transcription in cells. Some cancer types such as leukemia are over-represented by them, whereas some common cancer types such as lung cancer are under-represented by them. Across 12 major cancer types, while their genomic mutation patterns are similar to that of oncogenes, their expression patterns are more similar to that of tumor-suppressor genes. Their expression profile in six human organs propose that they mainly function as tumor suppressor in normal tissue. Our network analyses further show they have higher network degrees than both oncogenes and tumor-suppressor genes and thus tend to be the hub genes in the protein-protein interaction network. Our mutation, expression spectrum, and network analyses might help explain why some cancer types are specifically associated with them. Finally, our results suggest that the functionally altering mutations in "double-agent" genes and oncogenes are the main driving force in cancer development, because non-silent mutations are biasedly distributed toward these two gene sets across all 12 major cancer types.

摘要

一般来说,遗传成分在癌症发展中的作用是癌症生物学家感兴趣的领域。有趣的是,一些基因同时具有致癌和肿瘤抑制功能。在本研究中,我们通过数据库搜索和文本挖掘系统地鉴定了这些基因。我们发现它们中的大多数是转录因子或激酶,并具有双重生物学功能,例如,它们在细胞中既能正向调节转录,也能负向调节转录。一些癌症类型,如白血病,它们在其中的占比过高,而一些常见癌症类型,如肺癌,它们在其中的占比过低。在12种主要癌症类型中,虽然它们的基因组突变模式与癌基因相似,但其表达模式与肿瘤抑制基因更相似。它们在六种人体器官中的表达谱表明,它们在正常组织中主要发挥肿瘤抑制作用。我们的网络分析进一步表明,它们在网络中的连接度高于癌基因和肿瘤抑制基因,因此往往是蛋白质-蛋白质相互作用网络中的枢纽基因。我们的突变、表达谱和网络分析可能有助于解释为什么某些癌症类型与它们有特定关联。最后,我们的结果表明,“双重作用”基因和癌基因中的功能改变突变是癌症发展的主要驱动力,因为在所有12种主要癌症类型中,非同义突变偏向于分布在这两组基因中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/13e858669884/41389_2018_34_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/150716f084c6/41389_2018_34_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/f762245d9f34/41389_2018_34_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/4c793be81bcc/41389_2018_34_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/88c7200ec89b/41389_2018_34_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/ce23ad434ef5/41389_2018_34_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/42defb0d12f2/41389_2018_34_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/56342a3442b6/41389_2018_34_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/93b60409c3a7/41389_2018_34_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/35894be3d70f/41389_2018_34_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/13e858669884/41389_2018_34_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/150716f084c6/41389_2018_34_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/f762245d9f34/41389_2018_34_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/4c793be81bcc/41389_2018_34_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/88c7200ec89b/41389_2018_34_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/ce23ad434ef5/41389_2018_34_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/42defb0d12f2/41389_2018_34_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/56342a3442b6/41389_2018_34_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/93b60409c3a7/41389_2018_34_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/35894be3d70f/41389_2018_34_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5437/5852963/13e858669884/41389_2018_34_Fig10_HTML.jpg

相似文献

1
Double agents: genes with both oncogenic and tumor-suppressor functions.双重角色基因:兼具致癌和抑癌功能的基因。
Oncogenesis. 2018 Mar 13;7(3):25. doi: 10.1038/s41389-018-0034-x.
2
Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.癌基因与肿瘤抑制基因:比较基因组学与网络视角
BMC Genomics. 2015;16 Suppl 7(Suppl 7):S8. doi: 10.1186/1471-2164-16-S7-S8. Epub 2015 Jun 11.
3
Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.机器学习分类和癌症突变的结构-功能分析揭示了癌基因和肿瘤抑制基因中驱动位点的独特动态和网络特征。
J Chem Inf Model. 2018 Oct 22;58(10):2131-2150. doi: 10.1021/acs.jcim.8b00414. Epub 2018 Oct 3.
4
Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.参与人类乳腺癌的活化癌基因和假定的肿瘤抑制基因。
Cancer Treat Res. 1992;63:15-60. doi: 10.1007/978-1-4615-3088-6_2.
5
Suppressor genes in breast cancer: an overview.乳腺癌中的抑癌基因:综述
Cancer Treat Res. 1992;61:45-57. doi: 10.1007/978-1-4615-3500-3_3.
6
Recessive oncogenes.隐性癌基因。
Cancer. 1993 Feb 1;71(3 Suppl):1179-86. doi: 10.1002/1097-0142(19930201)71:3+<1179::aid-cncr2820711442>3.0.co;2-b.
7
New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.癌症中微小RNA功能的新见解:癌基因-微小RNA-肿瘤抑制基因网络
Front Mol Biosci. 2017 Jul 7;4:46. doi: 10.3389/fmolb.2017.00046. eCollection 2017.
8
Cancer genes.癌症基因。
West J Med. 1993 Mar;158(3):273-8.
9
Integrated transcriptome interactome study of oncogenes and tumor suppressor genes in breast cancer.乳腺癌中癌基因与肿瘤抑制基因的综合转录组相互作用组研究
Genes Dis. 2018 Nov 20;6(1):78-87. doi: 10.1016/j.gendis.2018.10.004. eCollection 2019 Mar.
10
Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.癌基因和抑癌基因的体细胞突变模式存在显著差异。
Oncol Rep. 2011 Dec;26(6):1539-46. doi: 10.3892/or.2011.1443. Epub 2011 Sep 1.

引用本文的文献

1
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.LZTR1是一种促进侵袭并抑制凋亡的黑色素瘤癌基因。
Oncogene. 2025 Aug 30. doi: 10.1038/s41388-025-03538-2.
2
Prognostic and tumor microenvironmental features of gastric cancer revealed by macrophage polarization and protein lactylation-related genes.巨噬细胞极化和蛋白质乳酰化相关基因揭示的胃癌预后及肿瘤微环境特征
Front Genet. 2025 Jul 2;16:1541489. doi: 10.3389/fgene.2025.1541489. eCollection 2025.
3
Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from and Against Malignant Glioma: An In Silico to In Vitro Approach.

本文引用的文献

1
The Varied Roles of Notch in Cancer.Notch在癌症中的多种作用。
Annu Rev Pathol. 2017 Jan 24;12:245-275. doi: 10.1146/annurev-pathol-052016-100127. Epub 2016 Dec 5.
2
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.浆细胞样变异型膀胱癌中频繁出现的体细胞CDH1功能丧失突变。
Nat Genet. 2016 Apr;48(4):356-8. doi: 10.1038/ng.3503. Epub 2016 Feb 22.
3
Substantial contribution of extrinsic risk factors to cancer development.外在风险因素对癌症发展的重大贡献。
评估大麻色烯、大麻二酚及来自[具体来源未给出]的相关化合物对恶性胶质瘤的抗肿瘤潜力:从计算机模拟到体外实验的方法。
Int J Mol Sci. 2025 Jun 13;26(12):5688. doi: 10.3390/ijms26125688.
4
Quitting Your Day Job in Response to Stress: Cell Survival and Cell Death Require Secondary Cytoplasmic Roles of Cyclin C and Med13.因应激而辞去日常工作:细胞存活与细胞死亡需要细胞周期蛋白C和Med13的胞质辅助作用
Cells. 2025 Apr 25;14(9):636. doi: 10.3390/cells14090636.
5
Revealing cancer driver genes through integrative transcriptomic and epigenomic analyses with Moonlight.利用Moonlight通过整合转录组学和表观基因组学分析揭示癌症驱动基因。
PLoS Comput Biol. 2025 Apr 21;21(4):e1012999. doi: 10.1371/journal.pcbi.1012999. eCollection 2025 Apr.
6
Sociobiology meets oncology: unraveling altruistic cooperation in cancer cells and its implications.社会生物学与肿瘤学相遇:揭示癌细胞中的利他合作及其影响。
Exp Mol Med. 2025 Feb;57(1):30-40. doi: 10.1038/s12276-024-01387-9. Epub 2025 Jan 7.
7
Re-evaluation of the relationship between PrPc expression and patient prognosis in primary esophageal squamous cell carcinoma and primary hepatocellular carcinoma.原发性食管鳞状细胞癌和原发性肝细胞癌中PrPc表达与患者预后关系的重新评估
Sci Rep. 2024 Dec 28;14(1):31122. doi: 10.1038/s41598-024-82398-4.
8
CancerPro: deciphering the pan-cancer prognostic landscape through combinatorial enrichment analysis and knowledge network insights.CancerPro:通过组合富集分析和知识网络洞察来解读泛癌预后格局。
NAR Genom Bioinform. 2024 Nov 21;6(4):lqae157. doi: 10.1093/nargab/lqae157. eCollection 2024 Dec.
9
Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review).预测乳腺癌驱动突变的新进展:精准肿瘤学的工具(综述)。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5447. Epub 2024 Oct 25.
10
In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications.基于计算机的 RNA 异构体筛选,以鉴定具有治疗应用潜力的癌症驱动子外显子。
Nat Commun. 2024 Aug 15;15(1):7039. doi: 10.1038/s41467-024-51380-z.
Nature. 2016 Jan 7;529(7584):43-7. doi: 10.1038/nature16166. Epub 2015 Dec 16.
4
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.TSGene 2.0:一个基于文献更新的肿瘤抑制基因知识库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1023-31. doi: 10.1093/nar/gkv1268. Epub 2015 Nov 20.
5
Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.在一例野生型胃肠道间质瘤病例中,通过全外显子组测序鉴定出神经纤维瘤蛋白1和MYC相关因子X基因的体细胞功能丧失突变。
BMC Cancer. 2015 Nov 10;15:887. doi: 10.1186/s12885-015-1872-y.
6
NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings.NCG 5.0:来自癌症突变筛查的癌症基因及相关特性的人工整理数据库的更新
Nucleic Acids Res. 2016 Jan 4;44(D1):D992-9. doi: 10.1093/nar/gkv1123. Epub 2015 Oct 29.
7
TP53: an oncogene in disguise.TP53:伪装的癌基因。
Cell Death Differ. 2015 Aug;22(8):1239-49. doi: 10.1038/cdd.2015.53. Epub 2015 May 29.
8
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
9
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.癌症病因。组织间癌症风险的差异可由干细胞分裂次数来解释。
Science. 2015 Jan 2;347(6217):78-81. doi: 10.1126/science.1260825.
10
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects.对12种肿瘤类型的基因表达模式进行比较,确定了一个以TP53突变和细胞周期缺陷为特征的癌症超级集群。
Oncogene. 2015 May 21;34(21):2732-40. doi: 10.1038/onc.2014.216. Epub 2014 Aug 4.